Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
21,509 Breast Cancer
clinical trials

Breast Cancer Clinical Trial
Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
Status: Enrolling
Updated: 9/24/2013
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
Status: Enrolling
Updated: 9/24/2013
New York Weill Cornell Cancer Center at Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
Status: Enrolling
Updated: 9/24/2013
University of South Florida College of Medicine
mi
from
Tampa, FL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
Status: Enrolling
Updated: 9/24/2013
Bridgeport Hospital
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
Status: Enrolling
Updated: 9/24/2013
Providence Saint-Joseph Medical Center
mi
from
Burbank, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast
Status: Enrolling
Updated: 7/22/2009
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer
Status: Enrolling
Updated: 1/5/2011
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Cancer Screening and Prevention Program for High Risk Women
Status: Enrolling, Phase
Updated: 12/31/1969
NYU Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Ellis Fischel Cancer Center at University of Missouri - Columbia
mi
from
Columbia, MO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Hurley Medical Center
mi
from
Flint, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Harrison Poulsbo Hematology and Onocology
mi
from
Poulsbo, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
University of California Davis Cancer Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Group Health Capitol Hill Campus
mi
from
Seattle, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Franciscan Cancer Center at St. Joseph Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Via Christi Cancer Center at Via Christi Regional Medical Center
mi
from
Wichita, KS
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Northeast Georgia Cancer Care, LLC - Medical Oncology
mi
from
Athens, GA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
University of Colorado Cancer Center - Anschutz Cancer Pavilion
mi
from
Aurora, CO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Mary Bird Perkins Cancer Center - Baton Rouge
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Overlake Cancer Center at Overlake Hospital Medical Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Alta Bates Summit Comprehensive Cancer Center
mi
from
Berkeley, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Billings Clinic - Downtown
mi
from
Billings, MT
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Illinois CancerCare - Canton
mi
from
Canton, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Rocky Mountain Oncology
mi
from
Casper, WY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
East Bay Radiation Oncology Center
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Adena Regional Medical Center
mi
from
Chillicothe, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
John B. Amos Cancer Center
mi
from
Columbus, GA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Grandview Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Samaritan North Cancer Care Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Grady Memorial Hospital
mi
from
Delaware, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Community Cancer Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Green Bay Oncology - Escanaba
mi
from
Escanaba, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Providence Regional Cancer Partnership
mi
from
Everett, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Northeast Georgia Medical Center
mi
from
Gainesville, GA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Cancer Center of Kansas-Independence
mi
from
Independence, KS
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Cleveland Clinic Cancer Center
mi
from
Independence, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Foote Memorial Hospital
mi
from
Jackson, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Kalispell Medical Oncology at KRMC
mi
from
Kalispell, MT
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Parvin Radiation Oncology
mi
from
Kansas City, MO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Research Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Great Lakes Cancer Institute - Lapeer Campus
mi
from
Lapeer, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Doctor's Hospital of Laredo
mi
from
Laredo, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
St. Joseph Regional Medical Center
mi
from
Lewiston, ID
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Lewistown Hospital
mi
from
Lewistown, PA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Illinois CancerCare - Macomb
mi
from
Macomb, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
HealthEast Cancer Care at St. John's Hospital
mi
from
Maplewood, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Cancer Center of Kansas, PA - McPherson
mi
from
McPherson, KS
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Providence Cancer Center at Providence Hospital
mi
from
Mobile, AL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Mercy Memorial Hospital
mi
from
Monroe, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Clemens Regional Medical Center
mi
from
Mount Clemens, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
New Ulm Medical Center
mi
from
New Ulm, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Community Cancer Center
mi
from
Normal, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Epic Care - Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Providence St. Peter Hospital Regional Cancer Center
mi
from
Olympia, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Illinois CancerCare-Peoria
mi
from
Peoria, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Mercy Regional Cancer Center at Mercy Hospital
mi
from
Port Huron, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Pottstown Memorial Regional Cancer Center
mi
from
Pottstown, PA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Reid Hospital & Health Care Services
mi
from
Richmond, IN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Southern Regional Medical Center
mi
from
Riverdale, GA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Phelps County Regional Medical Center
mi
from
Rolla, MO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Dixie Regional Medical Center - East Campus
mi
from
Saint George, UT
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Park Nicollet Cancer Center
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KS
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
St. Francis Cancer Center at St. Francis Medical Center
mi
from
Shakopee, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Mercy Hospital Springfield
mi
from
Springfield, MO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Mount Nittany Medical Center
mi
from
State College, PA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Lakeview Hospital
mi
from
Stillwater, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Legacy Meridian Park Hospital
mi
from
Tualatin, OR
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Sutter Solano Medical Center
mi
from
Vallejo, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Maui Memorial Medical Center
mi
from
Wailuku, HI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Saint John Macomb-Oakland Hospital
mi
from
Warren, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Ruth G. McMillan Cancer Center at Greene Memorial Hospital
mi
from
Xenia, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Genesis Healthcare System
mi
from
Zanesville, OH
Click here to add this to my saved trials
Gastroenterology, Oncology, Rheumatology Clinical Trial
Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer
Status: Enrolling
Updated: 9/12/2012
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Predicting Pathological Response Within the 1st Week of Chemotherapy Using Diffuse Optical Spectroscopic Imaging
Status: Enrolling
Updated: 4/15/2016
Beckman Laser Institute
mi
from
Irvine, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Vaccine Therapy in Treating Patients With Ductal Carcinoma In Situ of the Breast
Status: Enrolling, Phase I, II
Updated: 7/9/2009
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer
Status: Enrolling, Phase I, II
Updated: 1/21/2014
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Oncology Clinical Trial
I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Loyola University
mi
from
Maywood, IL
Click here to add this to my saved trials
Oncology Clinical Trial
I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Pennsylvania (U Penn)
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Oregon Health & Science Institute (OHSU)
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Kansas
mi
from
Westwood, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Characterization of Circulating Tumor Cells (CTC-s) in Patients With Locally Advanced or Metastatic Stage IV Breast Cancer
Status: Enrolling, Phase
Updated: 3/30/2018
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radiotherapy (APBI) in Women With Early Stage Breast Cancer Using the Contura MLB
Status: Enrolling
Updated: 1/9/2013
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radiotherapy (APBI) in Women With Early Stage Breast Cancer Using the Contura MLB
Status: Enrolling
Updated: 1/9/2013
William Beaumont Hospital-Royal Oak
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Lymphedema Clinical Trial
Two Pneumatic Compression Devices in the Treatment of Lower Extremity Lymphedema
Status: Enrolling, Phase IV
Updated: 12/31/1969
Carolinas Rehabilitation
mi
from
Charlotte, NC
Click here to add this to my saved trials
Lymphedema Clinical Trial
Two Pneumatic Compression Devices in the Treatment of Lower Extremity Lymphedema
Status: Enrolling, Phase IV
Updated: 12/31/1969
HOPE Research Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Michigan Comprehensive Cancer Center Onc Dept
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase I Study of MGAH22 in Patients With Refractory HER2 Positive Cancers
Status: Enrolling
Updated: 12/14/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Cosmetic Evaluation of Lumpectomy Versus Oncolytic Mammoplasty With Bilateral Breast Reduction for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/8/2015
South Atlantic Radiation Oncology, LLC
mi
from
Supply, NC
Click here to add this to my saved trials
Oncology, Orthopedics / Podiatry Clinical Trial
Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors
Status: Enrolling, Phase I
Updated: 6/11/2013
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials